Literature DB >> 17986190

Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae.

Elizabeth A Shakhnovich1, Derek Sturtevant, John J Mekalanos.   

Abstract

Virstatin is a previously described small molecule inhibitor of Vibrio cholerae virulence. We have demonstrated that the molecule inhibits the activity of the transcriptional activator ToxT, thereby preventing elaboration of the toxin co-regulated pilus (TCP) and cholera toxin in vitro and in vivo in O1 strains of V. cholerae. While strains of the O1 and O139 serogroups are the cause of most epidemic and endemic cholera currently seen globally, sporadic disease caused by strains of non-O1/non-O139 serogroups suggests that understanding the pathogenic mechanisms of these unusual strains is relevant for disease. Although some non-O1/non-O139 strains have acquired the pathogenicity island that encodes the TCP, the role that this essential colonization factor of O1/O139 strains plays in the virulence of non-O1/non-O139 strains has not been determined. In this study, we utilize virstatin in a 'chemical genetic approach' to examine the role of ToxT, and thus by inference TCP, in the colonization of a panel of predominantly non-O1/non-O139 tcp+ strains. We identified nine strains whose colonization was resistant to virstatin inhibition in the infant mouse model. These strains presumably colonize by a TCP-independent mechanism or contain a naturally occurring virstatin-resistant ToxT. Four strains contained the typical toxT gene found in O1/O139 strains (toxT(EPI)) isolated from cholera epidemics. Interruption of toxT in one of these strains did not affect colonization of the infant mouse small intestine. The remaining five strains were found to contain a sequence divergent toxT gene that has been previously designated toxT(ENV) because of its occurrence in isolates of V. cholerae from the environment. We show that ToxT(ENV) is resistant to virstatin in two separate heterologous systems and is necessary for efficient colonization of the infant mouse small intestine. These results support the new concept that chemical genetic probes for the in vivo function or expression of virulence genes can be used to identify strains that express alternative virulence factors or novel regulatory systems that are functional in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986190     DOI: 10.1111/j.1365-2958.2007.05984.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  12 in total

Review 1.  Chemical biology applied to the study of bacterial pathogens.

Authors:  Rebecca Anthouard; Victor J DiRita
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

2.  N-terminal residues of the Vibrio cholerae virulence regulatory protein ToxT involved in dimerization and modulation by fatty acids.

Authors:  Brandon M Childers; Xiaohang Cao; Gregor G Weber; Borries Demeler; P John Hart; Karl E Klose
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

3.  VasH is a transcriptional regulator of the type VI secretion system functional in endemic and pandemic Vibrio cholerae.

Authors:  Maya Kitaoka; Sarah T Miyata; Teresa M Brooks; Daniel Unterweger; Stefan Pukatzki
Journal:  J Bacteriol       Date:  2011-09-23       Impact factor: 3.490

Review 4.  Long Chain Fatty Acids and Virulence Repression in Intestinal Bacterial Pathogens.

Authors:  Mary K Mitchell; Melissa Ellermann
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

5.  Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.

Authors:  Tucker Maxson; Douglas A Mitchell
Journal:  Tetrahedron       Date:  2015-10-09       Impact factor: 2.457

Review 6.  The complexity of ToxT-dependent transcription in Vibrio cholerae.

Authors:  Gregor G Weber; Karl E Klose
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

7.  Selective and Efficient Elimination of Vibrio cholerae with a Chemical Modulator that Targets Glucose Metabolism.

Authors:  Young Taek Oh; Hwa Young Kim; Eun Jin Kim; Junhyeok Go; Wontae Hwang; Hyoung Rae Kim; Dong Wook Kim; Sang Sun Yoon
Journal:  Front Cell Infect Microbiol       Date:  2016-11-16       Impact factor: 5.293

8.  A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT.

Authors:  Anne K Woodbrey; Evans O Onyango; Maria Pellegrini; Gabriela Kovacikova; Ronald K Taylor; Gordon W Gribble; F Jon Kull
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

9.  Molecular dynamics simulation (MDS) analysis of Vibrio cholerae ToxT virulence factor complexed with docked potential inhibitors.

Authors:  Ibrahim Torktaz; Ali Najafi; Reza Golmohamadi; Sorour Hassani
Journal:  Bioinformation       Date:  2018-03-31

10.  Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa.

Authors:  Francesco Imperi; Ersilia V Fiscarelli; Daniela Visaggio; Livia Leoni; Paolo Visca
Journal:  Front Cell Infect Microbiol       Date:  2019-03-11       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.